Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2019

Jan 28, 2019

3091_iss_2019-01-28_b11a88d4-377a-4f9c-91b7-6663a977b72d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Other
Date 24/01/2019
Limit for number of shares 15 %
Limit for number of votes 15 %
After the transaction
Quantity
Shares 5,670,805
Directly held voting rights 5,670,805
Indirectly held voting rights 0
Percentage
Directly held shares 12.86132 %
Directly held voting rights 12.86132 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 12.86132 % 5,670,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
10.77295 % 4,750,000
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled

Total 23.63427 % 10,420,805

Group total holdings Voting rights 10,420,805

Percentage of voting rights 23.63427

Notes (other relevant informations according to law)

Flaggningen avser utlån av aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 44 091 921 utestående aktier i Oncopeptides per 24 januari 2019, dagen då flaggningsskyldigheten uppstod.

Published

28/01/2019 11:20

Contact

Name Jonas Brambeck

Phone +46708791937 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25